Camblong Jurgi 4

What Happened

• Jurgi Camblong, Executive Chairman and Director of SOPHiA GENETICS (SOPH), sold 22,486 shares in open-market transactions on July 6, 2026. The filing reports a weighted-average price of $5.25 per share for total proceeds of approximately $118,164. The sales were effected to satisfy tax withholding obligations related to restricted stock units that vested earlier in July.

Key Details

• Transaction date: July 6, 2026
• Report filed: July 7, 2026 (timely)
• Shares sold: 22,486
• Weighted-average price reported: $5.25; price range across multiple trades: $4.97–$5.43 (footnote offers breakdown on request)
• Purpose/footnotes: Sold to satisfy tax withholding on RSU vestings (footnote F1); executed under a pre-established Rule 10b5-1(c) plan and were non-discretionary
• Shares owned after transaction: Not disclosed in this summary filing

Context

• These sales were tax-withholding transactions tied to RSU vesting and executed under a 10b5-1 plan, which generally indicates pre-planned, non-discretionary sales rather than opportunistic insider selling. For more granular price-per-trade details or current beneficial ownership, consult the full Form 4 (Accession 0001840706-26-000246).